Potter B J, Elias E, Jones E A
J Lab Clin Med. 1976 Sep;88(3):427-39.
The possibliity that the disturbed immunity associated with primary biliary cirrhosis (PBC) includes abnormal metabolism of the complement system has been investigated by conducting simultaneous studies of the turnover of highly purified, hemolytically active, 125-i-labeled C3 (third component of complement) and 131i-albumin in seven control subjects and nine patients with PBC. Aliquots of each 125i-C3 preparation were injected, together with 131i-albumin, into one or two normal subjects and one to three patients with PBC and plasma and urine radioactivity data were analyzed. In all patients with PBC disappearance of 125i from plasma was much more rapid than in controls. In five of these patients no terminal monexponential decline of 125i occurred. The mean fractional catabolic rate (FCR) of C3 was higher in PBC (4.23 +/- 0.32 [S.E.M.] per cent IV pool per hour) than in controls (2.02 +/- 0.08% IV pool per hour, p less than 0.0005). In contrast, the mean FCR of albumin was similar in PBC (11.4 +/- 1.29 per cent IV pool per day) and controls (11.5 +/- 0.76 per cent IV pool per day), suggesting that the increased FCR of C3 in PBC was not due to a nonspecific process. There was no correlation between values for the FCR of C3 and indices of cholestasis. The mean synthetic rate of C3 was higher in PBC (2.94 +/- 0.48 MG. PER KILOGRAM PER HOUR) THAN IN CONTROls (1.03 +/- 0.11 mg. per kilogram per hour, p less than 0.0025). In five patients relatively more C3 was extravascular than in controls. The results are consistent with PBC being associated with chronic activation of the complement system and increased tissue attachement of C3, phenomena which could be related to a process of pathogenic significance in this disease.
通过对7名对照者和9例原发性胆汁性肝硬化(PBC)患者同时进行高纯度、具有溶血活性的125碘标记C3(补体第三成分)和131碘标记白蛋白周转的研究,探讨了与PBC相关的免疫紊乱是否包括补体系统代谢异常。将每份125碘 - C3制剂的等分试样与131碘标记白蛋白一起注入1至2名正常受试者和1至3例PBC患者体内,并分析血浆和尿液放射性数据。在所有PBC患者中,125碘从血浆中的消失速度比对照者快得多。在其中5例患者中,125碘未出现终末单指数下降。PBC患者中C3的平均分解代谢率(FCR)(每小时4.23±0.32 [标准误]%静脉池)高于对照者(每小时2.02±0.08%静脉池,p<0.0005)。相比之下,PBC患者(每天11.4±1.29%静脉池)和对照者(每天11.5±0.76%静脉池)白蛋白的平均FCR相似,这表明PBC中C3的FCR增加并非由于非特异性过程。C3的FCR值与胆汁淤积指标之间无相关性。PBC患者中C3的平均合成率(每千克每小时2.94±0.48毫克)高于对照者(每千克每小时1.03±0.11毫克,p<0.0025)。5例患者血管外的C3相对比对照者多。这些结果与PBC与补体系统的慢性激活及C3组织附着增加相关一致,这些现象可能与该疾病的致病过程有关。